Amgen: A Financial Analysis

Paper Summary:

The paper examines the current issues and challenges that Amgen faces and analyzes the outlook for Amgen's future growth. The paper looks at Amgen's current and past business practices and evaluates the company's financial statements in order to determine its ability to maintain shareholder value. The paper concludes that Amgen needs to focus on patient safety and its public image in order to maintain the current position it has in the marketplace.

Outline:
Executive Summary
Introduction
Company profile
Political, Social, and Environmental issues
Current Situation
Technological Issues that Impeded Product Development
SWOT Analysis
Overview of Key Business Strategies
Industry Environment Resources
Mission, Goals, and Ethics
Financial Ratios
Conclusions/ Recommendations/ Outlook

From the Paper:

"Amgen has a commitment to maintain shareholder value. Although their ultimate commitment is to the patients that they serve, there is still an obligation to preserve and grow value for the investor. In order to overcome these challenges, Amgen must focus on new product lines to spread the risk over a number of product lines. They must also work to eliminate the potential for any further actions against them, as far as safety is concerned. There is not much that they can do to prevent the possibility the other companies will attempt to develop similar products to theirs. It is inevitable in this type of business environment. However, they already have an excellent staff of legal professionals that is dedicated to defending them against these threats."

Sample of Sources Used:

• Amgen. (2006). Corporate Governance. December 2006, Retrieved June 24, 2007 from http://www.abgenix.com/about/corporate_governance_conduct_board.html
• Amgen (2007a). Company history. Retrieved June 24, 2007 from http://www.amgen.com/about/company_history.html.
• Amgen (2007b).Acquisition History. Retrieved June 24, 2007 from http://www.amgen.com/about/acquisitions.html.
• Amgen. (2007c). Our Mission and Values. Retrieved June 24, 2007 from http://www.amgen.com/about/mission_values.html.
• Choate (2007). Intellectual Property Litigation. Retrieved June 24, 2007 from http://www.choate.com/practice/litigation/intellectual_property_litigation/index.aspCostello, D. (2007). Amgen suffers another round of negative news. May 26, 2007. Los Angeles Times. Retrieved June 14, 2007 fromhttp://www.latimes.com/business/la-fi-amgen26may26,1,6763926.story?coll=la- headlines-business

More papers on Amgen: A Financial Analysis:

• Analytical Essay # 105446 : "A Business Analysis of Amgen, Inc"
• Term Paper # 104043 : "Latin America: A Financial Analysis"
• Analytical Essay # 3987 : "A Financial Analysis of Boeing Inc."

APA Citation:

MLA Citation: